Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Appendix 3B

21 Sep 2012 07:22

RNS Number : 8257M
Oilex Limited
21 September 2012
 



21 September 2012

 

Dear Sirs

 

Appendix 3B

 

We enclose an Appendix 3B detailing the following changes to listed Options and unlisted Employee Performance Rights:

 

Listed Options

 

Issue 4 Ordinary Shares upon the exercise of 4 listed $0.15 options

 

 

2008 Employee Performance Rights

 

22,000 Tranche 3 - Converted

 

Accordingly, 22,004 Ordinary Shares are expected to be admitted to trading on the AIM market on 25 September 2012.

 

For and on behalf of Oilex Ltd

 

 

Max Cozijn

Chairman

 

 

cc: Directors - BMc/RB/SB/RM

 

 

 

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

 

 

Appendix 3B

 

New issue announcement,application for quotation of additional securitiesand agreement

 

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

 

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005, 01/08/2012.

 

 

Name of entity

 OILEX LTD

 

ABN

50 078 652 632

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1.

+Class of +securities issued or to be issued

 

Fully Paid Ordinary Shares

2.

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

22,004 Ordinary Shares

3.

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

 

Fully paid ordinary shares:

 

Tranche 3 2008 - 22,000 Employee Performance Rights exercised

 

4 listed options exercised at 15 cents per share

 

 

4.

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

Yes

 

 

 

 

 

5.

Issue price or consideration

 

4 Ordinary shares at 15 cents per share

22,000 Ordinary shares - Nil

 

 

 

 

6.

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

Issue of 22,000 ordinary shares upon exercise of unlisted Employee Performance Rights by employees pursuant to the Employee Performance Rights Plan

 

Ordinary shares issued upon exercise of 4 listed Options expiring 7 September 2015

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

 

 

6b

The date the security holder resolution under rule 7.1A was passed

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

 

 

6f

Number of securities issued under an exception in rule 7.2

 

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

 

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

 

7.

Dates of entering +securities into uncertificated holdings or despatch of certificates

 

 

 

18 September 2012

 

 

Number

+Class

8.

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

 

354,676,843

 

 

151,994,967

 

Ordinary Shares

 

 

Options exercisable at 15 cents expiring 7 September 2015

 

 

Number

+Class

9.

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

16,687,500

 

75,000

 

4,150,000

 

8,737,500

 

75,000

 

 

 

$0.30 Options due 10/11/2012

$0.50 Options due 01/08/2013

$0.30 Options due 01/07/2014

$0.37 Options due 10/11/2014

$0.63 Options due 01/08/2015

 

10.

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

 

 

 

 

 Part 2 ‑ Bonus issue or pro rata issue [Item 11 to 33 - Not Applicable]

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

Entities that have ticked box 34(a) [Items 35 to 42 - Not Applicable]

Additional securities forming a new class of securities

 

 

 

 

Quotation agreement

 

1. +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2. We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

·; There is no reason why those +securities should not be granted +quotation.

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

·; We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the +securities to be quoted, it has been provided at the time that we request that the +securities be quoted.

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3. We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4. We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

 

 

 

 

Sign here: .............................................. Date: 21 September 2012

 

(Chairman)

Print name: Max Cozijn

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFLRADILFIF
Date   Source Headline
1st Jul 20157:27 amRNSTrading Halt
29th Jun 20157:00 amRNSCambay Field - Gas Sales Commence
10th Jun 20157:00 amRNSPAC Partners Broker Research
8th Jun 20157:00 amRNSCambay-73 : Pipeline & pre-commissioning completed
8th Jun 20157:00 amRNSChange of Registered Office
20th May 20158:33 amRNSAppendix 3B - Cancellation of Unlisted Options
18th May 20157:00 amRNSPESA Deal Day Presentation
14th May 201510:16 amRNSJPDA 06-103 Joint Venture
13th May 20157:00 amRNSJPDA 06-103 Joint Venture
11th May 20158:51 amRNSInterview with Oilex Managing Director
11th May 20157:00 amRNSOILEX Investor Presentation May 2015
30th Apr 20157:00 amRNSQuarterly Report 31 March 2015
29th Apr 20157:00 amRNSInterview with Oilex Managing Director
28th Apr 20157:00 amRNSCambay-73 : Production Facilities Completed
20th Apr 20157:03 amRNSOILEX Investor Presentation April 2015
16th Apr 20157:06 amRNSCambay Field - Reserves and Contingent Resources
14th Apr 20159:51 amRNSAppointment of Australian Broker
26th Mar 20157:00 amRNSCambay-73 - Construction of Oil & Gas Facilities
20th Mar 20158:37 amRNSInterview with Managing Director
19th Mar 20157:00 amRNSAppointment of UK Broker
18th Mar 20157:00 amRNSAppendix 3B - Exercise of Listed Options
16th Mar 201512:31 pmRNSOilex Investor Presentation March 2015
9th Mar 20157:46 amRNSIndia Operations Update with Addendum
9th Mar 20157:00 amRNSIndia Operations Update
19th Feb 20157:00 amRNSAppendix 3B - Issue of Employee Options
12th Feb 20159:28 amRNSInterview with Oilex Managing Director
11th Feb 20157:00 amRNSInterim Financial Report half-year 31 Dec 2014
5th Feb 20157:00 amRNSOilex Investor Presentation - February 2015
3rd Feb 20157:00 amRNSAppendix 3X J Auld
30th Jan 20157:00 amRNSQuarterly Report 31 December 2014
28th Jan 20157:00 amRNSAppointment of UK Based Non-Executive Director
27th Jan 20157:00 amRNSAppendix 3B - Cancellation of Unlisted Options
21st Jan 20157:00 amRNSInterview with Oilex Vice Chairman
20th Jan 20157:00 amRNSChange of Share Registry
19th Jan 20157:00 amRNSCambay-77H - Gas Sales Agreement Endorsed
30th Dec 20147:00 amRNSAdmission of Shares and Total Voting Rights
24th Dec 20147:00 amRNSNotice of Change in Substantial Holding
23rd Dec 20149:16 amRNSAppendix 3Y R Miller
23rd Dec 20149:14 amRNSAppendix 3Y M Cozijn
22nd Dec 20148:50 amRNSCleansing Notice and Appendix 3B
19th Dec 20149:10 amRNSCompletion of SPP Raising A$2.5 Million
12th Dec 20147:00 amRNSCambay Basin demonstrates strong economics
11th Dec 20147:00 amRNSCanning Basin SPA 17 AO
8th Dec 20147:00 amRNSCambay-77H - Successful Well Test
5th Dec 20149:18 amRNSShare Purchase Plan - Extension to ClosingDate
5th Dec 20148:31 amRNSBhandut-3 - Gas Sales Agreement Endorsed
1st Dec 20147:00 amRNSCambay-77H - Production Test Complete
28th Nov 20148:52 amRNSUK Shareholders Access to Share Purchase Plan
28th Nov 20147:00 amRNSInterview with Oilex Ltd Managing Director
26th Nov 20147:00 amRNSShare Purchase Plan Offer Document

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.